儿童气道手术中使用经鼻高流量氧疗以减少低氧事件:一项随机对照试验
这项在澳大利亚五家三级医院开展的多中心随机试验纳入0-16岁需无管上气道手术的儿童,1:1随机接受经鼻高流量氧疗或标准氧疗(氧流量最高6 L/min),按中心和年龄分层。主要终点为无需因抢救性给氧中断手术的成功麻醉,高流量组236/267(88%)vs 标准组229/261(88%)(校正RR 1.02,95%CI 0.96-1.08,p=0.82)。低氧事件(SpO2<90%)高流量组51/297(19%)vs 标准组57/284(22%)(RR 0.86,95%CI 0.58-1.24)。作者认为两种给氧方式均可作为维持氧合的合适选择。
要点
- 儿童无管上气道手术中,经鼻高流量氧疗未减少因抢救性给氧而中断手术的比例:高流量组236/267(88%)vs 标准组229/261(88%),校正RR 1.02(95%CI 0.96-1.08),p=0.82。
- 低氧事件(SpO2<90%)高流量组51/297(19%)vs 标准组57/284(22%),RR 0.86(95%CI 0.58-1.24),未达统计学显著。
- 其他预设次要终点均无显著组间差异;鼻出血、喉痉挛、支气管痉挛、低氧血症、心动过缓、心脏骤停、低血压或死亡等不良事件两组相似。
- 作者认为,经鼻高流量氧疗或标准氧疗均可作为儿童上气道手术维持氧合的合适选择。
适用人群与场景
- 0-16岁需无管上气道手术的儿童,来自澳大利亚五家三级医院。
- 同一儿童再次手术间隔超过2周可纳入,符合该条件的重复手术被视为独立事件。
诊断标准与关键阈值
- 抢救性给氧事件定义:因给予正压通气而中断手术,方式包括球囊面罩、插入气管导管或喉罩以改善氧合。
- 低氧事件定义:SpO2<90%。
处置流程与药物剂量
- 经鼻高流量氧疗组给予经鼻高流量氧疗。
- 标准氧疗组给予标准氧疗,氧流量最高6 L/min。
- 随机化按中心和年龄(<1岁、1-4岁、5-16岁)分层。
研究设计与关键结果
- 多中心随机试验,581例手术(487名儿童)随机分配至高流量氧疗(297例手术)或标准治疗(284例手术);排除后528例手术(高流量组267例、标准组261例)纳入意向性分析,共483名儿童(男293例、女190例)。
- 主要终点(无需因抢救性给氧中断手术的成功麻醉):高流量组236/267(88%)vs 标准组229/261(88%),校正RR 1.02(95%CI 0.96-1.08),p=0.82。
- 低氧事件(SpO2<90%):高流量组51/297(19%)vs 标准组57/284(22%),RR 0.86(95%CI 0.58-1.24)。
- 其他预设次要终点均无显著组间差异;鼻出血、喉痉挛、支气管痉挛、低氧血症、心动过缓、心脏骤停、低血压或死亡等不良事件两组相似。
证据类型、等级与局限
- 证据类型:多中心随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,经鼻高流量氧疗或标准氧疗均可作为儿童上气道手术维持氧合的合适选择。
- 该结果提示经鼻高流量氧疗未减少因抢救性给氧中断手术的比例,与标准氧疗相比不良事件无差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Tubeless upper airway surgery in children is a complex procedure in which surgeons and anaesthetists share the same operating field. These procedures are often interrupted for rescue oxygen therapy. The efficacy of nasal high-flow oxygen to decrease the frequency of rescue interruptions in children undergoing upper airway surgery is unknown.
METHODS: In this multicentre randomised trial conducted in five tertiary hospitals in Australia, children aged 0-16 years who required tubeless upper airway surgery were randomised (1:1) by a web-based randomisation tool to either nasal high-flow oxygen delivery or standard oxygen therapy (oxygen flows of up to 6 L/min). Randomisation was stratified by site and age (<1 year, 1-4 years, and 5-16 years). Subsequent tubeless upper airway surgery procedures in the same child could be included if there were more than 2 weeks between the procedures, and repeat surgical procedures meeting this condition were considered to be independent events. The oxygen therapy could not be masked, but the investigators remained blinded until outcome data were locked. The primary outcome was successful anaesthesia without interruption of the surgical procedure for rescue oxygenation. A rescue oxygenation event was defined as an interruption of the surgical procedure to deliver positive pressure ventilation using either bag mask technique, insertion of an endotracheal tube, or laryngeal mask to improve oxygenation. There were ten secondary outcomes, including the proportion of procedures with a hypoxaemic event (SpO2 <90%). Analyses were done on an intention-to-treat (ITT) basis. Safety was assessed in all enrolled participants. This trial is registered in the Australian New Zealand Clinical Trials Registry, ACTRN12618000949280, and is completed.
FINDINGS: From Sept 4, 2018, to April 12, 2021, 581 procedures in 487 children were randomly assigned to high-flow oxygen (297 procedures) or standard care (284 procedures); after exclusions, 528 procedures (267 assigned to high-flow oxygen and 261 assigned to standard care) in 483 children (293 male and 190 female) were included in the ITT analysis. The primary outcome of successful anaesthesia without interruption for tubeless airway surgery was achieved in 236 (88%) of 267 procedures on high-flow oxygen and in 229 (88%) of 261 procedures on standard care (adjusted risk ratio [RR] 1·02, 95% CI 0·96-1·08, p=0·82). There were 51 (19%) procedures with a hypoxaemic event in the high-flow oxygen group and 57 (22%) in the standard care group (RR 0·86, 95% CI 0·58-1·24). Of the other prespecified secondary outcomes, none showed a significant difference between groups. Adverse events of epistaxis, laryngospasm, bronchospasm, hypoxaemia, bradycardia, cardiac arrest, hypotension, or death were similar in both study groups.
INTERPRETATION: Nasal high-flow oxygen during tubeless upper airway surgery did not reduce the proportion of interruptions of the procedures for rescue oxygenation compared with standard care. There were no differences in adverse events between the intervention groups. These results suggest that both approaches, nasal high-flow or standard oxygen, are suitable alternatives to maintain oxygenation in children undergoing upper airway surgery.
FUNDING: Thrasher Research Fund, the Australian and New Zealand College of Anaesthetists, the Society for Paediatric Anaesthesia in New Zealand and Australia.
参考来源
- Humphreys S, von Ungern-Sternberg BS, Taverner F, et al. High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial. Lancet Respir Med. 2024. PMID: 38788748. doi:10.1016/S2213-2600(24)00115-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。